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The Relevance of Mechanistic
Data to the Interpretation and
Extrapolation to Humans of
Rodent Carcinogenicity Data
I refer to Huffs response (1) to my letter to
EHP regarding the adequacy of the a2u-
globulin nephropathy mechanism of tumor
induction in male rats (2) and to the reponse
by Dietrich (3) to the points made by Huff
(1). Pursuit of the mechanisms by which
chemicals are toxic to mammals can bejusti-
fied in two ways. The first is that the acquisi-
tion of such knowledge may increase our
ability to prevent or attenuate human dis-
eases. The second is that mechanistic data
can contribute significantly to our ability to
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differentiate significant and trivial chemical
hazards and to assess likely risks to humans.
This latter justification can be illustrated by
the following statement: ifall chemicals that
are mutagenic in vitro were mutagenic and
carcinogenic to humans, and if all rodent
carcinogens posed an equal carcinogenic
hazard to humans, then there would be no
role for mechanistic studies. The fact that
these statements are self-evidently untrue
therefore provides the main justification for
the conduct ofmechanistic studies.
The value of the results of mechanistic
studies aimed at differentiating hazards
should be judged solely in terms of the
extent to which they either increase or
decrease the level ofconcern over the poten-
tial hazard posed to humans by exposure to
the substance under study. Within this con-
text, simple experiments, such as confirming
that an in vitromutagen is also mutagenic in
vivo or establishing the effect that changing
the route ofexposure, or the test species, has
on the carcinogenicity ofasubstance, qualify
as mechanistic studies. However, the term is
usually reserved for investigations that pro-
vide a framework within which the rodent
toxicity ofa substance can be explained and
extrapolated to humans.
Loose use ofthe term mechanistic stud-
ies can lead to confusion when the derived
results offer no guidance on human hazard
assessment. For example, it may be interest-
ing to establish that nitrogen mustard is clas-
togenic by virtue ofits ability to bind cova-
lently with DNA, while the similar activity
of etoposide is due to its ability to inhibit
topoisomerase II enzymes, but such knowl-
edge is ofno value for human hazard assess-
ment in the absence ofdata indicating that
one of these mechanisms of clastogenesis is
more relevant to human hazard assessment
than the other. This single example indicates
that when mechanistic data are invoked to
qualify the hazard of a rodent carcinogen,
there is a need to discuss the context ofthose
data and to make clearhow theyshould alter
our perception ofthe human hazard implied
bythe initial test data.
To date, there are no examples of a
mechanism of cancer induction in rodents
that is rigorously established and uniformly
accepted as being of no relevance to
humans. Further, given the potential for
occasional high accidental exposures to
chemicals and the existence ofhuman poly-
morphisms among the enzymes that acti-
vate or detoxify chemicals, and among the
enzymes and processes that maintain genet-
ic integrity, such an example is unlikely
ever to be documented. Nonetheless, there
are several proposed mechanisms of cancer
induction (rodent tumor etiologies) and
tumor types (e.g., B6C3F1 mouse liver
tumors) that carry a high level ofcertainty
regarding their probable irrelevance to
humans. The central issue therefore
becomes whether a given level of certainty
is acceptable or not. Whichever conclusion
is reached in such cases, a compromise will
have been made in the process. So, for
example, if a chemical induces specifically
renal or thyroid gland tumors in a lifetime
rat carcinogenicity bioassay and if those
tumors are preceded by the induction of
ax2u-globulin-mediated nephropathy or
thyroid-stimulating hormone-mediated
thyroid follicular cell proliferation, respec-
tively, then a decision will have to be made
regarding the relevance ofthose tumor eti-
ologies to humans.
The differences evident in the view-
points ofHuff(1) and Dietrich (3) are due
to both different starting premises regard-
ing the value of attempting to separate
mechanisms ofchemical carcinogenesis and
differences in their use and interpretation
of the available mechanistic data for the
cx2u-globulin-mediated nephropathy
mechanism. Those differences are of inter-
est at two levels. First, they lead to identifi-
cation of the key data by which to assess
whether or not humans will be subject to
this particular rodent tumor etiology.
Uncertainties over the sufficiency and the
significance of those data remain a valid
subject for future research. Second, the dif-
ferent viewpoints expressed confirm that
we have some way to go before we can all
share a common motivation for undertak-
ing mechanistic studies. Put simply, we will
make no useful progress until we can share
the motivation of attempting to improve
human hazard assessments within the limit-
ed confines of the resources available for
the task, mindful that compromises will
have to be made ifwe are to distinguish, for
example, the human hazards posed by
exposure to the rodent kidney carcinogens
limonene and diethyl nitrosamine. That
motivation will lead only to rational and
balanced discussion of the relevant peer-
reviewed data. As summarized in the old
Chinese adage, "if you want to find the
truth about an issue, don't take either side."
Attempts to guard the scientific high
ground and to search for certainty, ostensi-
bly on behalf of less well-informed col-
leagues, or attempts to dismiss rodent car-
cinogenicity data by reference to insecure
and preliminary mechanistic constructs
must be equally resisted.
The success or failure ofthe margin of
exposure (MOE) approach to nongenotox-
ic carcinogen hazard assessment proposed
by the U.S. EPAwill depend largely on the
extent to which such common ground can
be found and secured in the future.
JohnAshby
Zeneca Central Toxicology Laboratory
Alderley Park, Cheshire, United Kingdom
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o2u-Globulin Nephropathy
and Ravens: Do Ravens of a
Different Feather Flock
Together?
The scientific community is well served by
the continued interest in mechanisms of
x2u-globulin nephropathy and its poten-
tial relationship to nephrocarcinogenesis in
rodents. The article by Huff (1), com-
mented on byAshby (2), and with a subse-
quent reply by Huff(3) sparked a renewed
polemic. In addition, a letter by Dietrich
(4) further fuels this scholarly debate.
Having contemplated the diverse opin-
ions from these authors, we are concerned
that some of the statements based on pub-
lished data from our laboratories (5-7)
might be viewed in different context than
originally presented, leading to potential
misinterpretations. To clarify these state-
ments from other scientists, we feel that it is
necessary to touch upon the following facts.
Over the last decade, we have developed
extensive preclinical safety evaluation data
to support the human use of gabapentin.
Gabapentin is a safe and effective drug for
epilepsy based on rigorous review by regula-
tory agencies worldwide. From these stud-
ies, risk benefit comparisons were made
between animal and human dosages. Wistar
rats in the 2-year carcinogenicity bioassay
showed significantly higher gabapentin
exposures (as measured by plasma concen-
trations and area under the curve) than
humans at therapeutic exposures.
When exposed to gabapentin for 2
years at 10-15 multiples of the human
exposure, rats developed mild a2u protein
accumulation as judged by histomorpho-
logic examination. After 13 weeks ofexpo-
sure, the incidence of ux2u-globulin accu-
mulation was similar across the treatment
and control groups, and the degree of
severity was higher in the treated groups.
The extent ofa2u protein accumulation in
the kidneys of male rats treated with
gabapentin diminished after 52 weeks,
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